Professor Brendan Crabb

Professor Brendan Crabb

AC FAA FAHMS

Director and CEO
Burnet Institute
Fellow
Elected in 2015
VIC
Citation on election

Professor Brendan Crabb has made a number of discoveries of major significance relating to our understanding of human malaria, a field in which he is a major internationally recognised figure. He was primarily responsible for the discovery of the malaria translocon, a protein machine that constitutes perhaps the leading new drug target in malaria. He also pioneered genetic technologies in human malaria, describing the first gene knockout in this organism. He has made a significant broader contribution to health and medical research, most notably through his leadership of the Burnet Institute and the Association of Australia Medical Research Institutes.

Find out more

Whether you’re looking to nominate a colleague for an award, make a donation to the Academy or simply find out more about the work we do, research we advance and health policy advice we provide, sign up to our mailing list today.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.